Skip to main content
Fig. 4 | Cancer Imaging

Fig. 4

From: 68Ga-PSMA PET/CT-based multivariate model for highly accurate and noninvasive diagnosis of clinically significant prostate cancer in the PSA gray zone

Fig. 4

DCA of prediction model and each indicator for detecting CSPCa in patients with PSA grey zone. The prediction model is the combination of the 68Ga-PSMA PET/CT SUVmax, PV and FPSA/TPSA. DCA, decision curve analysis; 68Ga-PSMA, 68Ga-labeled prostate-specific membrane antigen; PET/CT, positron emission tomography/computed tomography; MRI, magnetic resonance imaging; CSPCa, clinically significant prostate cancer; PSA, prostate-specific antigen

Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us